CFR Q1 2026 Earnings Earnings Beat Driven by Strong Core Performance SGU Q1 2026 Earnings Strong Earnings Performance Amid Seasonal Peak RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline HWBK Q1 2026 Earnings Strong EPS Performance Amid No Revenue Guidance TPST Q1 2026 Earnings Significant EPS Miss Amid No Revenue Stock Gains 276 Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground